211 related articles for article (PubMed ID: 38674895)
1. The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.
Wade U; Pascual-Figal DA; Rabbani F; Ernst M; Albert A; Janssens I; Dierckxsens Y; Iqtadar S; Khokhar NA; Kanwal A; Khan A
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674895
[TBL] [Abstract][Full Text] [Related]
2. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
[TBL] [Abstract][Full Text] [Related]
3. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J
Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.
Portincasa P; Bonfrate L; Scribano ML; Kohn A; Caporaso N; Festi D; Campanale MC; Di Rienzo T; Guarino M; Taddia M; Fogli MV; Grimaldi M; Gasbarrini A
J Gastrointestin Liver Dis; 2016 Jun; 25(2):151-7. PubMed ID: 27308645
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
7.
Cayzeele-Decherf A; Pélerin F; Leuillet S; Douillard B; Housez B; Cazaubiel M; Jacobson GK; Jüsten P; Desreumaux P
World J Gastroenterol; 2017 Jan; 23(2):336-344. PubMed ID: 28127207
[TBL] [Abstract][Full Text] [Related]
8. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome
Li L; Cui H; Li T; Qi J; Chen H; Gao F; Tian X; Mu Y; He R; Lv S; Chu F; Xu B; Wang P; Lei H; Xu H; Wang C
Front Pharmacol; 2020; 11():1210. PubMed ID: 32982718
[TBL] [Abstract][Full Text] [Related]
10. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
11. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.
Zhou Q; Verne ML; Fields JZ; Lefante JJ; Basra S; Salameh H; Verne GN
Gut; 2019 Jun; 68(6):996-1002. PubMed ID: 30108163
[TBL] [Abstract][Full Text] [Related]
12. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome].
Tsukanov VV; Rzhavicheva OS; Vasjutin AV; Dunaevskaja OV; Tonkih JL; Bronnikova EP
Ter Arkh; 2016; 88(8):40-45. PubMed ID: 27636926
[TBL] [Abstract][Full Text] [Related]
14. Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial.
Palsson OS; Peery A; Seitzberg D; Amundsen ID; McConnell B; Simrén M
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00276. PubMed ID: 33512807
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
[TBL] [Abstract][Full Text] [Related]
16. Homeopathy for treatment of irritable bowel syndrome.
Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
[TBL] [Abstract][Full Text] [Related]
17. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
[TBL] [Abstract][Full Text] [Related]
18. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
Lackner JM; Ma CX; Keefer L; Brenner DM; Gudleski GD; Satchidanand N; Firth R; Sitrin MD; Katz L; Krasner SS; Ballou SK; Naliboff BD; Mayer EA
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1147-57. PubMed ID: 23524278
[TBL] [Abstract][Full Text] [Related]
19. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
Patel A; Hasak S; Cassell B; Ciorba MA; Vivio EE; Kumar M; Gyawali CP; Sayuk GS
Aliment Pharmacol Ther; 2016 Aug; 44(3):246-58. PubMed ID: 27240555
[TBL] [Abstract][Full Text] [Related]
20. Tegaserod for the treatment of irritable bowel syndrome.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
